Abstract
AbstractMagnetic resonance imaging (MRI) is a highly valuable diagnostic tool as it is a noninvasive technique that offers high spatial resolution. The use of contrast agents (CAs) can enhance the precision and specificity of MRI for disease diagnosis, but their imaging signals are “always on” regardless of whether they interact with target tissues or cells. Hence, a poor target‐to‐background signal ratio (TBR) is inevitably produced. In contrast, activatable CAs with high performance have been used to significantly improve the TBR, thus these CAs have also received extensive attention and undergone in‐depth research. In this review, we summarized the recent advances in design strategies and principles of activatable MR CAs, including ion conversion, self‐assembly, and disassembly. Additionally, we analyzed the advantages of these strategies in biomedical applications from in vitro biodetection to in vivo disease diagnosis compared to the outcomes of conventional MR CAs. Finally, we discussed the potential limitations, proposed solutions, and future perspectives of these activatable CAs.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
